These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15357491)

  • 1. [After taking the table, immediate sex? New potency pill allows more time for love life].
    MMW Fortschr Med; 2004 May; 146(19):64. PubMed ID: 15357491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phosphodiesterase-5 inhibitor with broad temporal effectiveness window].
    MMW Fortschr Med; 2004 Apr; 146(16):62. PubMed ID: 15222506
    [No Abstract]   [Full Text] [Related]  

  • 3. [PDE-5 inhibitor with improved pharmacokinetics. Far-reaching return to normality].
    MMW Fortschr Med; 2003 Mar; 145(11):56-7. PubMed ID: 12688198
    [No Abstract]   [Full Text] [Related]  

  • 4. Prescribing all phosphodiesterase 5 inhibitors to a patient with erectile dysfunction--a realistic and feasible option in everyday clinical practice--outcomes of a simple treatment regime.
    Ströberg P; Hedelin H; Ljunggren C
    Eur Urol; 2006 May; 49(5):900-7; discussion 907. PubMed ID: 16564126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Erectile dysfunction and phosphodiesterase type 5 inhibitors].
    Roumeguère T; Sternon J; Schulman CC
    Rev Med Brux; 2003 Jun; 24(3):169-75. PubMed ID: 12891884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive pharmacotherapy to cure erectile dysfunction: fact or fiction?
    Burnett AL
    Urology; 2005 Feb; 65(2):224-30. PubMed ID: 15708027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
    Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Once daily therapy of erectile dysfunction. "Flexible love life without time constraints"].
    Porst H
    MMW Fortschr Med; 2009 Jun; 151(23):55. PubMed ID: 19591357
    [No Abstract]   [Full Text] [Related]  

  • 10. Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy.
    Lee AG; Newman NJ
    Am J Ophthalmol; 2005 Oct; 140(4):707-8. PubMed ID: 16226524
    [No Abstract]   [Full Text] [Related]  

  • 11. PDE-5 inhibitors: current status and future trends.
    Masson P; Lambert SM; Brown M; Shabsigh R
    Urol Clin North Am; 2005 Nov; 32(4):511-25, viii. PubMed ID: 16291042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New potency pill. Treating (vascular) bed failure].
    MMW Fortschr Med; 2003 Jan; 145(5):51. PubMed ID: 12619215
    [No Abstract]   [Full Text] [Related]  

  • 13. PDE5 inhibitors: looking beyond ED.
    Jackson G
    Int J Clin Pract; 2003 Apr; 57(3):159-60. PubMed ID: 12723713
    [No Abstract]   [Full Text] [Related]  

  • 14. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial.
    Young JM; Feldman RA; Auerbach SM; Kaufman JM; Garcia CS; Shen W; Murphy AM; Beasley CM; Hague JA; Ahuja S
    J Androl; 2005; 26(3):310-8. PubMed ID: 15866997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil Lilly ICOS.
    Rotella DP
    Curr Opin Investig Drugs; 2003 Jan; 4(1):60-5. PubMed ID: 12625031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA
    Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biology and pharmacology of PDE-5-inhibitor therapy for erectile dysfunction.
    Corbin JD; Francis SH
    J Androl; 2003; 24(6 Suppl):S38-41. PubMed ID: 14581493
    [No Abstract]   [Full Text] [Related]  

  • 19. An update on the PDE-5 inhibitors (PDE-5i).
    McCullough AR
    J Androl; 2003; 24(6 Suppl):S52-8. PubMed ID: 14581496
    [No Abstract]   [Full Text] [Related]  

  • 20. [7 years PDE-5 inhibitor for therapy of erection disorders].
    Krankenpfl J; 2005; 43(7-10):267. PubMed ID: 16518894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.